TNGX - Wall Street Estimates - Tango Therapeutics, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 3.115

0.161 %

$ 335 M

Market Cap

-2.71

P/E

Price Target Average

370.84%

Revenue Forecast Estimate

--1.71%

EBIT Estimate

34.55%

Net Income Estimate

--8.65%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Tango Therapeutics, Inc.

Wall Street analysts predict an average 1-year price target for TNGX of $14.7 , with forecasts ranging from a low of $13 to a high of $18 .

TNGX Lowest Price Target Wall Street Target

13 USD 317.34%

TNGX Average Price Target Wall Street Target

14.7 USD 370.84%

TNGX Highest Price Target Wall Street Target

18 USD 477.85%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free